ClinicalTrials.Veeva

Menu

The Development of Diagnosis and Prognosis Predictive Model for Peripheral Nerve Disease

H

Huazhong University of Science and Technology

Status

Completed

Conditions

Peripheral Nerve Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06843642
2025-0015-01

Details and patient eligibility

About

This is a retrospective observational cohort study (MRN-PND), aiming to explore the utility of contrast-enhanced MRN (ceMRN) compared to plain MRN in diagnosing peripheral nerve diseases and predicting the prognosis of patients with these conditions. Additionally, artificial intelligence (AI) methods are employed to enhance the diagnostic accuracy of MRN for peripheral nerve diseases and to precisely predict disease outcomes.

Enrollment

10,000 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Patients who underwent MRN scanning at Wuhan Union Hospital between January 2015 and January 2025;
  2. Age > 18 years;
  3. Definitive clinical diagnosis (either healthy individuals or patients with a specific condition).

Exclusion criteria:

  1. Poor quality of imaging;
  2. Incomplete clinical data or loss to follow-up;
  3. Unclear clinical diagnosis.

Trial design

10,000 participants in 2 patient groups

Healthy Volunteers
Patients with Peripheral Nerve Disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems